World's smallest, leadless pacemaker yields positive results

May 19, 2017, Emory University
The Micra Transcatheter Pacing System is one-tenth the size of conventional pacemakers. Credit: Medtronic

An international clinical trial, led by Emory Heart & Vascular Center researchers, reports excellent outcomes for the world's smallest, minimally invasive cardiac pacemaker, the Micra Transcatheter Pacing System (TPS).

The study results were reported by Emory at the Heart Rhythm Society Scientific Session 2017 as a late breaker clinical trial and simultaneously published in Heart Rhythm.

Unlike conventional pacemakers, the vitamin-sized Micra TPS does not require the use of wires, known as "leads." These leads, threaded through blood vessels to connect to the heart, are sometimes the source of serious medical complications such as infection and vein injury.

A total of 795 from more than 20 countries were enrolled in the prospective, non-randomized, multi-center trial. The goal was to assess the safety and performance of Micra TPS in a "real-world clinical practice setting" and in hands of new operators.

According to the study, the Micra TPS device was successfully implanted in 792 of 795 registry patients (99.6 percent) by 149 implanters at 96 centers. Eighty-seven percent of these149 operators performing the procedures did not have any prior experience implanting the Micra TPS.

"The major strength of this study is the inclusion of patients from around the globe and different operators with variable levels of experience with this technology," says Mikhael El-Chami, MD, associate professor of medicine, Emory School of Medicine who presented the results at the scientific session.

The pacemaker is delivered via a catheter through the femoral vein and positioned inside the right ventricle of the heart. Credit: Medtronic

"The findings are reassuring and reinforce the positive results seen in the prior investigational study providing another layer of evidence to physicians and patients that this leadless pacemaker can be implanted safely and successfully."

El-Chami says a positive surprise of the study is the low rate of complications specifically the lower rate of pericardial effusion as compared to the original study. Major complications were seen in 1.5 percent of patients within 30 days of implant in this study.

This compares favorably to what was seen in the investigational study (2.89 percent 30-day complication rate) and to what is seen with conventional pacemakers (typically 4-5 percent acute complication rate).

The device is weighs less than a small coin and is only a little longer than a U.S. nickel. Credit: Medtronic

Major complications included cardiac effusion/perforation, device dislodgment and sepsis.

El-Chami and his Emory Heart & Vascular Center colleagues were the first in Georgia, and among the first in the United States, to begin implanting the Micra TPS in 2014. Emory was the top enrolling U.S. site in the trial.

During the procedure, the tiny device—approximately one-tenth the size of a conventional pacemaker—is delivered through a catheter inserted in the femoral vein to the inside of the heart. Once positioned, it securely attaches to the endocardial tissue of the heart wall and sends electrical pulses to the heart through electrode tips whenever it senses an abnormal rhythm.

According to El-Chami, this study reports solely on the short-term outcomes of this novel . Intermediate and long-term outcomes, which are important to know, will be reported later. The study intends to enroll approximately 1830 patients and enrollment is currently ongoing.

Explore further: World's smallest Medtronic Micra pacemaker: Cardiac pacing game change?

More information: Paul R. Roberts et al. A Leadless Pacemaker in the Real-World Setting: The Micra Transcatheter Pacing System Post-Approval Registry, Heart Rhythm (2017). DOI: 10.1016/j.hrthm.2017.05.017

Related Stories

World's smallest Medtronic Micra pacemaker: Cardiac pacing game change?

December 15, 2013
(Medical Xpress)—Device maker Medtronic has accomplished a feat in device miniaturization, this time in the form of an implantable cardiac device the size of a large vitamin. Earlier this month, Minneapolis-based Medtronic ...

Minneapolis Heart Institute Foundation implants its first world's smallest cardiac pacemaker

May 5, 2014
The Minneapolis Heart Institute Foundation (MHIF) announced today the first implant of the world's smallest pacemaker at the Minneapolis Heart Institute. The device was implanted as part of a global clinical trial and the ...

'World's smallest pacemaker' appears promising in human trial

May 18, 2015
(HealthDay)—The world's smallest pacemaker is safe and effective in patients with symptomatic bradycardia, according to the first human clinical trial of the device. The findings were scheduled to be presented at the annual ...

Heart expert sees pacemaker as cardiac management milestone

June 11, 2014
(Medical Xpress)—The BBC reported Monday that the world's smallest' pacemaker, the Micra Transcatheter Pacing System, was fitted for the first time in England. The pacemaker is one-tenth the size of traditional models. ...

FDA approves first pacemaker without wires from Medtronic

April 6, 2016
The Food and Drug Administration has approved the first pacemaker to do away with electrical wires that have long been a shortcoming of internal heart devices.

World's smallest, leadless heart pacemaker implanted at Ohio State

May 6, 2014
It's about the size of a large vitamin pill and, for the first time in Ohio, the smallest heart pacemaker available is being tested at The Ohio State University Wexner Medical Center.

Recommended for you

'Smart stent' detects narrowing of arteries

June 19, 2018
For every three individuals who have had a stent implanted to keep clogged arteries open and prevent a heart attack, at least one will experience restenosis—the renewed narrowing of the artery due to plaque buildup or scarring—which ...

Marriage may protect against heart disease / stroke and associated risk of death

June 18, 2018
Marriage may protect against the development of heart disease/stroke as well as influencing who is more likely to die of it, suggests a pooled analysis of the available data, published online in the journal Heart.

Deaths from cardiac arrest are misclassified, overestimated

June 18, 2018
Forty percent of deaths attributed to cardiac arrest are not sudden or unexpected, and nearly half of the remainder are not arrhythmic—the only situation in which CPR and defibrillators are effective—according to an analysis ...

Tick-borne meat sensitivity linked to heart disease

June 15, 2018
University of Virginia School of Medicine researchers have linked sensitivity to an allergen in red meat—a sensitivity spread by tick bites—with a buildup of fatty plaque in the arteries of the heart. This buildup may ...

Tobacco aside, e-cigarette flavorings may harm blood vessels

June 14, 2018
Flavor additives used in electronic cigarettes and related tobacco products could impair blood vessel function and may be an early indicator of heart damage, according to new laboratory research in Arteriosclerosis, Thrombosis ...

The molecules that energize babies' hearts

June 14, 2018
A metabolic process that provides heart muscle with energy fails to mature in newborns with thickened heart walls, according to a Japan–Canada research team.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.